Advanced in Heart Failure

Philip Wenzel

Obere Zahlbacher Str. 67, 
Mainz, RP, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Heart Failure
Obere Zahlbacher Str. 67, 
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Philip Wenzel practices in Mainz, Germany. Mr. Wenzel is rated as an Advanced expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Hypertension, Hypertensive Heart Disease, Mesenteric Venous Thrombosis, Heart Attack, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 161 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 27 articles in the study of Heart Failure.

Gender
Male

Locations

Obere Zahlbacher Str. 67, Mainz, RP 55131, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable

161 Total Publications

Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials.
Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials.
Journal: Thrombosis research
Published: June 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wenzel's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile